Stellar results in a bladder cancer study have prompted Astellas to raise its peak sales prediction for Pfizer-partnered antibody-drug conjugate Padcev, although its new menopause therapy Veozah isn’t ramping up as hoped.
Copyright © 2024 | WordPress Theme by MH Themes